Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Multiple epidermal growth factor-like domains protein 10 (MEGF10) is a membrane receptor that binds to phosphatidylserine on apoptotic cells and mediates their phagocytosis, especially by macrophages and astrocytes[1][2][5]. It also promotes amyloid-beta peptide uptake in the brain and regulates myogenesis, impacting muscle cell adhesion, motility, and proliferation by interacting with Notch signaling pathways[1][2][6]. In the retina, MEGF10 helps establish mosaic spacing of interneurons. Mutations in MEGF10 can cause severe congenital myopathies (including EMARDD), and its expression has been linked to neuropsychiatric and neurodegenerative conditions[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Multiple epidermal growth factor-like domains protein 10 (MEGF10).